Archive

Posts Tagged ‘biotech ETFs’

Trouble Ahead For This Biotech ETF?

April 22nd, 2016

biotechRick Pendergraft:  The biotech sector has had a rough go of it since last July. The SPDR S&P Biotech ETF (NYSEArca: XBI) lost over half of its value from last July’s high to the February low, falling from $90.75 to $44.11. Read more…

NASDAQ:IBB, NYSE:XBI

Big Biotech ETF Faces Key Technical Test

March 18th, 2016

biotechDavid Fabian:  Those who have followed our blog for some time now know that we are big proponents of technical analysis in reading the trends of the market.  This type of examination can also be applied when we are analyzing individual sectors or industries that have diverged from the conventional path of the market. Read more…

NASDAQ:BIB, NASDAQ:IBB

A More Viable Way To Tap Into Pharmaceutical and Biotech Investing

October 13th, 2015

biotechJJ Feldman:  Tapping into the pharmaceuticals (pharma) and biotechnology sectors can be intimidating, and picking winners in this corner of the health care market is tough. Read more…

NYSE:FBT, NYSE:XBI

Biotech Sector Bounce Looks To Be Coming

October 1st, 2015

biotechRick Pendergraft: The third quarter came to a close yesterday and it wasn’t a good one for the overall market, as the S&P 500 lost 6.94% for its worst quarterly performance in four years. Read more…

NASDAQ:BIB, NASDAQ:IBB

Biotech ETFs Offer A Great Buying Opportunity Right Now

September 29th, 2015

biotechKyle Anderson:  Biotech stocks have gotten crushed in recent weeks, with the Nasdaq Biotechnology Index falling 15.5% in the last month and 25% from its July highs. Read more…

NASDAQ:BIB, NASDAQ:IBB, NYSE:FBT

Biotech ETF Slide Likely To Continue

September 23rd, 2015

biotechRick Pendergraft:  During the first seven months of the year, the biotech sector was among the best performing sectors in the market. The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) gained 31.22% from the beginning of the year through the close on July 20. Read more…

NASDAQ:BIB, NASDAQ:IBB

The Top Biotech ETF To Buy Right Now

June 15th, 2015

biotechKyle Anderson: Our favorite biotech ETF has been one of the biggest winners of this sector’s 2015 rally… Read more…

NASDAQ:BIB, NASDAQ:IBB, NYSE:FBT

Changing The Face Of Biotech Investing

June 1st, 2015

biotechLawrence Meyers: If you’re interested in seeking out investments in new biotechnology and pharmaceutical advances that could change the face of health care, then you may want to look at some ETFs that may take advantage of the advance in biosimilars. Read more…

NASDAQ:IBB, NYSE:PPH

Pharma’s Record Setting First Quarter

May 12th, 2015

biotechKyle Anderson: The pharmaceutical industry saw record-setting M&A activity in the first quarter of 2015. Read more…

NYSE:XPH

Amgen, Inc., Gilead Sciences, Inc., Biogen Inc, Celgene Corporation: Is A Biotech Bubble Looming?

April 14th, 2015

dollar money bubbleJay Taylor: If you own shares of biotechnology stocks, chances are you’re having a great 2015. Read more…

NASDAQ:BIB, NASDAQ:IBB, NYSE:FBT

Gilead Sciences, Inc., Amgen, Inc., Biogen Inc: Is This A Biotech Bubble?

April 1st, 2015

dollar money bubbleKyle Anderson: Wall Street pundits are claiming we are on the precipice of a biotech bubble because biotechnology stocks have been soaring. Read more…

NASDAQ:BIB, NASDAQ:IBB

2015 Biotech ETF Surge Reflects Healthy Sector

March 23rd, 2015

biotechJim Bach: Popular biotech ETF First Trust NYSE Arca Biotechnology Index Fund (NYSE Arca: FBT) is up 23.5% on the year. It’s among our top performing picks for year-to-date performance from our “stocks to invest in” list. Read more…

NASDAQ:BIB, NASDAQ:IBB, NYSE:FBT

The Best Biotech ETF To Buy and One To Avoid

October 14th, 2014

biotechKyle Anderson:  A biotech ETF (exchange-traded fund) is an excellent way to capture profits from the entire industry with just one investment. Read more…

NASDAQ:BIB, NASDAQ:IBB, NYSE:FBT

Biotechs With Massive Upside

September 15th, 2014

biotechEverybody knows that biotech ideas can become huge gainers for investors, but understanding the technology platforms, the unmet needs and the valuations can be daunting, especially in spaces where a number of players are developing products. Read more…

NASDAQ:BIB, NASDAQ:IBB

ETF Impact On Biotech Earnings

July 31st, 2014

biotechnologyThe Q2 earnings season has so far been great for biotech companies with most of them giving solid quarterly updates. Biotech giant Gilead Sciences (GILD) continued with its exceptional performance in this quarter as well, beating the Zacks Consensus Estimate Read more…

NASDAQ:BIB, NASDAQ:IBB, NYSE:BBH, NYSE:PJP




Copyright 2009-2016 WBC Media, LLC